Macropa-NH2 is the precursor to Macropa-NCS, which is conjugated to trastuzumab as well as to the prostate-specific membrane antigen-targeting compound RPS-070 and is a promising therapeutic radionuclide applied in the treatment of soft-tissue metastases.

纯度：≥98%

CAS：2146095-13-6